Muhammad Akram, MD
Clinical Cardiac Electrophysiology · Madisonville, KYNPI 1902803737
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $9,377 of the $15,475 with a category attached, or 60.6%. Abbott accounts for 65.0% of it on its own, with 33 other manufacturers making up the rest. Reporting peaked in 2023 at $5,249 and has fallen 69.3% since, to $1,613 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in KY, where the typical reported total is $16,637.
Across 305 payments — averaging $50.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$10K
- Medtronic$2K
- Novartis$790
- Amgen$373
- Johnson & Johnson$333
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$319
- plus $1K from 28 others
What the payments were for
- Travel & lodging$9,37761%
- Food & beverage$6,01739%
- Education$801%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 95 | $10,054 |
| Medtronic | 19 | $2,251 |
| Novartis | 51 | $790 |
| Amgen | 24 | $373 |
| Johnson & Johnson(2 entities) | 19 | $333 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 18 | $319 |
| Pfizer | 19 | $247 |
| Sanofi-aventis U.S. LLC | 8 | $158 |
| E.r. Squibb & Sons, L.L.C. | 11 | $143 |
| AstraZeneca | 2 | $92 |
| Boehringer Ingelheim | 5 | $82 |
| Actelion Pharmaceuticals US, Inc. | 5 | $74 |
| Atricure, Inc. | 2 | $60 |
| Boston Scientific | 3 | $57 |
| Cvrx, Inc. | 1 | $48 |
| Philips North America LLC | 3 | $44 |
| Baxter Healthcare | 2 | $38 |
| Elutia, Inc. | 1 | $38 |
| Inspire Medical Systems, Inc. | 2 | $29 |
| Angiodynamics, Inc. | 1 | $24 |
| Averitas Pharma Inc. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| United Therapeutics Corporation | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| Siemens Medical Solutions USA, Inc. | 1 | $17 |
| Electromed, Inc. | 1 | $16 |
| Terumo Medical Corporation | 1 | $16 |
| Scpharmaceuticals Inc. | 1 | $16 |
| Novo Nordisk | 1 | $15 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $14 |
| Merck | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $12 |
| Braemar Manufacturing, LLC | 1 | $11 |
| Kls-martin L.p. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Allure CRT Pacemaker$2,901
- AMPLATZER AMULET$2,454
- AVEIR$2,167
- ARCTIC FRONT ADVANCE$980
- Confirm Rx$359
- Anthem CRT Pacemaker$295
- PulseSelect$196
- Allure Quadra RF CRT Pacemaker$133
- NA$108
How this compares
$15,475 in reported general payments places this provider in the 45th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.
See all clinical cardiac electrophysiology providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 563 | $444,417 |
| UptraviSelexipag | 11 | $282,157 |
| XareltoRivaroxaban | 152 | $148,938 |
| EntrestoSacubitril/Valsartan | 24 | $17,046 |
| Amiodarone Hcl | 297 | $12,489 |
| BrilintaTicagrelor | 18 | $9,601 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 199 | $4,383 |
| Metoprolol Succinate | 450 | $3,897 |
| Ranolazine ErRanolazine | 76 | $2,499 |
| Flecainide Acetate | 59 | $1,891 |
| Rosuvastatin Calcium | 105 | $1,518 |
| Labetalol Hcl | 51 | $1,330 |
| Losartan Potassium | 153 | $1,135 |
| SotalolSotalol Hcl | 82 | $1,111 |
| ClopidogrelClopidogrel Bisulfate | 131 | $1,074 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $247 | $444,417563 claims |
| Actelion Pharmaceuticals US, Inc.Uptravi | $74 | $282,15711 claims |
| Johnson & JohnsonXarelto | $333 | $148,938152 claims |
| NovartisEntresto | $790 | $17,04624 claims |
| AstraZenecaBrilinta | $92 | $9,60118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.
Other clinical cardiac electrophysiology in Madisonville
- Johan AasboLexington$451K
- Rajdeep GaitondeLouisville$404K
- Jeffrey StidamLouisville$196K
- Gery TomassoniLexington$196K
- Kent MorrisLouisville$187K
- John LeeLexington$139K
- Joseph SouzaLexington$110K
- Kevin ParrottLouisville$60K
- Vedran OrucPaducah$56K
- Michael AntimisiarisPikeville$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.